KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis
- 30 September 2013
- journal article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 132 (3), 723-728
- https://doi.org/10.1016/j.jaci.2013.02.019
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosisAllergy, 2012
- Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosisBone, 2011
- Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literatureCurrent Opinion in Hematology, 2010
- Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patientsJournal of Allergy and Clinical Immunology, 2009
- Mast cells and mastocytosisBlood, 2008
- Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patientsAllergy, 2008
- Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response CriteriaEuropean Journal of Clinical Investigation, 2007
- Clonality and Molecular Pathogenesis of MastocytosisActa Haematologica, 2005
- Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasmNature Genetics, 1996
- Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.Proceedings of the National Academy of Sciences, 1995